Related Experiment Video
Updated: Jul 8, 2026
11:01
Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
Published on: August 30, 2011
[Autobiographical Memory in Alzheimer's Disease: Understanding to Better Support Patients]
Oumashankar Nunkessore1, Florence Bonfils2, Hélène Guedin3
1Court séjour gériatrique, hôpital Alexandra-Lepève, Dunkerque, France.
Summary
Alzheimer's disease (AD) significantly impairs autobiographical memory, affecting identity. This review explores AD's impact on memory, brain regions involved, and supportive strategies for patients and caregivers.
Area of Science:
- Neuroscience
- Psychology
- Gerontology
Background:
- Autobiographical memory is crucial for identity and psychosocial well-being.
- Alzheimer's disease (AD) causes progressive autobiographical memory decline, impacting personal narratives and self-perception.
Purpose of the Study:
- To provide an integrative review of autobiographical memory and its impairment in Alzheimer's disease.
- To discuss neuroanatomical correlates, preserved cognitive resources, and supportive strategies.
- To emphasize the role of caregivers and explore future research directions.
Main Methods:
- Integrative literature review.
- Discussion of neuroanatomical correlates (hippocampus, frontal/parietal cortices, amygdala).
- Examination of supportive strategies (multisensory stimulation, narrative reconstruction, immersive approaches).
Main Results:
- Autobiographical memory impairment in AD is linked to specific neuroanatomical changes.
- Cognitive resources and supportive strategies can mitigate memory loss effects.
- Family caregivers play a vital role in maintaining identity and memory continuity.
Conclusions:
- Understanding autobiographical memory decline in AD is essential for developing tailored interventions.
- Future research should focus on digital tools and integrative methodologies.
- Interventions should aim to support patient identity, autonomy, and psychosocial well-being.
More Related Videos
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
07:07Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
Published on: October 29, 2019
Related Concept Videos
01:14Autobiographical Memory
Autobiographical memory is a unique type of episodic memory that involves recollecting personal life experiences. It allows individuals to remember significant events from their past, creating a narrative of their lives. One interesting phenomenon related to autobiographical memory is the reminiscence bump. This effect refers to the tendency of adults to recall more events from their second and third decades of life — typically between ages 10 to 30 — than from other periods. This period is...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...